Genes such as ARF1, SLC25A5, and CDKN2A were significantly up-regulated in tumor samples, while genes such as SNCA, PRNP, and GLS were significantly down-regulated in tumor samples. The gene discussed is CDKN2A; the disease is neoplasm.